Skip NavigationSkip to Content
Return Return to Search Results

GSK-3a/ß and MEK inhibitors assist the microenvironment of tumor initiation

  1. Author:
    Hassan, Ghmkin
    Afify, Said M
    Zahra, Maram H
    Nawara, Hend M
    Kumon, Kazuki
    Iwasaki, Yoshiaki
    Salomon,David
    Seno, Akimasa
    Seno, Masaharu

  2. Author Address

    Okayama, 700-8530 Japan Department of Cancer Stem Cell Engineering, Faculty of Interdisciplinary Science and Engineering in Health Systems, Institute of Academic and Research, Okayama University., Damascus, Syria Department of Microbiology and Biochemistry, Faculty of Pharmacy, Damascus University., Shebin El Koum, Menoufia 32511 Egypt Division of Biochemistry, Chemistry Department, Faculty of Science, Menoufia University., Tsushima Naka, Kita, Okayama, 700-8530 Japan Research Core for Interdisciplinary Sciences, Graduate School of Natural Science and Technology, Okayama University., Washington, DC 20007 USA Department of Oncology, Lombardi Comprehensive Cancer Centre, Georgetown University., Okayama, 700-8530 Japan Health Service Center, Okayama University., Frederick, MD 21702 USA Center for Cancer Research, National Cancer Institute., The Laboratory of Natural Food and Medicine, Co, Ltd., Okayama, 700-8530 Japan., R&D Center, Katayama Chemicals Ind., Co. Ltd, 4.1.7 Ina, Minoh, Osaka, 562-0015 Japan.,
    1. Year: 2023
    2. Date: Jun
    3. Epub Date: 2023 04 01
  2. Journal: Cytotechnology
    1. 75
    2. 3
    3. Pages: 243-253
  4. Type of Article: Article
  1. Abstract:

    Induced pluripotent stem cells (iPSCs) are useful tools for modeling diseases and developing personalized medicine. We have been developing cancer stem cells (CSCs) from iPSCs with conditioned medium (CM) of cancer-derived cells as the mimicry of the microenvironment of tumor initiation. However, the conversion of human iPSCs has not always been efficient with only CM. In this study, human iPSCs reprogrammed from monocytes of healthy volunteers were cultured in a media containing 50% of the CM from human pancreatic cancer derived BxPC3 cells supplemented with a MEK inhibitor (AZD6244) and a GSK-3a/ß inhibitor (CHIR99021). The survived cells were assessed for the characteristics of CSCs in vitro and in vivo. As a result, they exhibited CSC phenotypes of self-renewal, differentiation, and malignant tumorigenicity. Primary culture of the malignant tumors of the converted cells exhibited the elevated expression of CSC related genes CD44, CD24 and EPCAM maintaining the expression of stemness genes. In conclusion, the inhibition of GSK-3a/ß and MEK and the microenvironment of tumor initiation mimicked by the CM can convert human normal stem cells into CSCs. This study could provide insights into establishing potentially novel personalized cancer models which could help investigate the tumor initiation and screening of personalized therapies on CSCs. The online version contains supplementary material available at 10.1007/s10616-023-00575-1. © The Author(s) 2023.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1007/s10616-023-00575-1
  3. PMID: 37181678
  4. PMCID: PMC10167063
  5. PII : 575

Library Notes

  1. Fiscal Year: FY2022-2023
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel